Owners, management and financials
CVR: 36494433
Previous names: REPOCEUTICALS ApS
DKK 88,000,000
Revenue
Net result: DKK -6,228,938,000
NIELS ERIK JESPERSEN HOLDING ApS (10-14,99%), Beier Holding ApS (10-14,99%)
4 more
CVR · view owners
Torsten Bjørn
Board: Henrik Bulskov (chair) and 2 members
CVR · view management
Active
Founded 16 January 2015
CVR · view overview
1 employee
CVR · 2018
Owner registered: DMZ HOLDING ApS
CVR · 19/09/2025
View the full event history
REPOCEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPOCEUTICALS ApS. The management consists of Torsten Bjørn. The board consists of Henrik Bulskov (chair), Charlotte Pahl and Christian Vinding Thomsen. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. Equity in the 2025 report amounted to DKK 6,245,088,000.
Selskabets formål er at udvikle repositionerede lægemidler samt dermed beslægtede aktiviteter
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 88 mio. | -6.2 mia. | 10.3 mia. | 6.2 mia. | - | |
| 202401/01/2024 – 31/12/2024 | 0 | -6.3 mio. | 12.1 mio. | 4.8 mio. | - | |
| 202301/01/2023 – 31/12/2023 | 0 | -5.2 mio. | 9.7 mio. | 2.8 mio. | - | |
| 202201/01/2022 – 31/12/2022 | 0 | -3.8 mio. | 9.5 mio. | 8.3 mio. | - | |
| 202101/01/2021 – 31/12/2021 | 0 | -4.4 mio. | 14.3 mio. | 12 mio. | - | |
| 202001/01/2020 – 31/12/2020 | 0 | -859 t. | 9.9 mio. | 5.2 mio. | - | |
| 201901/01/2019 – 31/12/2019 | 0 | -523 t. | 8.2 mio. | 6 mio. | - | |
| 201801/01/2018 – 31/12/2018 | 0 | -383 t. | 5 mio. | -356 t. | - | |
| 201701/01/2017 – 31/12/2017 | - | -78 t. | 2.5 mio. | 27 t. | - | |
| 201601/01/2016 – 31/12/2016 | - | -211 t. | 853 t. | 105 t. | - | |
| 201516/01/2015 – 31/12/2015 | - | -34 t. | 703 t. | 316 t. | - |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of REPOCEUTICALS A/S is 36494433.
The owners of REPOCEUTICALS A/S include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS.
The management of REPOCEUTICALS A/S consists of Torsten Bjørn.
The board of REPOCEUTICALS A/S consists of Henrik Bulskov, Charlotte Pahl and Christian Vinding Thomsen, with Henrik Bulskov as chair.
In 2025, REPOCEUTICALS A/S reported revenue of DKK 88,000,000.
REPOCEUTICALS A/S had 1 employee in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
REPOCEUTICALS A/S has published its annual report for 2025. Revenue came to DKK 88,000,000, and the net result was DKK -6,228,938,000.
As of May 28, 2026, Troels Peter Troelsen has left the board of directors of REPOCEUTICALS A/S.
As of October 22, 2025, Troels Peter Troelsen has joined the board of directors of REPOCEUTICALS A/S.
As of October 22, 2025, Henrik Bulskov has joined the board of directors of REPOCEUTICALS A/S.
As of October 21, 2025, Troels Peter Troelsen has left the board of directors of REPOCEUTICALS A/S.
As of October 21, 2025, Henrik Bulskov has left the board of directors of REPOCEUTICALS A/S.
As of September 19, 2025, DMZ HOLDING ApS is registered as an owner of REPOCEUTICALS A/S with an ownership share of 15%.
REPOCEUTICALS A/S has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -6,274,548.
As of June 27, 2025, Preben Møllegaard Grundtvig has left the board of directors of REPOCEUTICALS A/S.
As of June 27, 2025, Sigbjørn Georg Nielsen Kjærgård has left the board of directors of REPOCEUTICALS A/S.
REPOCEUTICALS A/S has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -5,199,745.
As of June 13, 2024, Troels Peter Troelsen has joined the board of directors of REPOCEUTICALS A/S.
As of June 13, 2024, Sigbjørn Georg Nielsen Kjærgård has joined the board of directors of REPOCEUTICALS A/S.
As of June 12, 2024, Troels Peter Troelsen has left the board of directors of REPOCEUTICALS A/S.
As of June 12, 2024, Sigbjørn Georg Nielsen Kjærgård has left the board of directors of REPOCEUTICALS A/S.
REPOCEUTICALS A/S has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -3,828,782.
As of May 24, 2023, Nete Søgaard Poulsen has left the board of directors of REPOCEUTICALS A/S.
REPOCEUTICALS A/S has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -4,402,347.
As of November 18, 2021, Beier Holding ApS is registered as an owner of REPOCEUTICALS A/S with an ownership share of 10%.
As of November 11, 2021, Anpartsselskabet af 11.11.2019 is registered as an owner of REPOCEUTICALS A/S with an ownership share of 10%.
REPOCEUTICALS A/S has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -858,803.
As of June 22, 2021, Christian Vinding Thomsen has joined the board of directors of REPOCEUTICALS A/S.
As of June 22, 2021, Charlotte Pahl has joined the board of directors of REPOCEUTICALS A/S.
As of June 21, 2021, Charlotte Pahl has left the board of directors of REPOCEUTICALS A/S.
REPOCEUTICALS A/S has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK -523,215.
As of February 20, 2020, PM Group Holding ApS is registered as an owner of REPOCEUTICALS A/S with an ownership share of 5%.
As of June 18, 2019, Troels Peter Troelsen has joined the board of directors of REPOCEUTICALS A/S.
As of June 18, 2019, Preben Møllegaard Grundtvig has joined the board of directors of REPOCEUTICALS A/S.
As of June 18, 2019, Henrik Bulskov has joined the board of directors of REPOCEUTICALS A/S.
As of June 18, 2019, Sigbjørn Georg Nielsen Kjærgård has joined the board of directors of REPOCEUTICALS A/S.
As of June 18, 2019, Nete Søgaard Poulsen has joined the board of directors of REPOCEUTICALS A/S.
As of June 18, 2019, Charlotte Pahl has joined the board of directors of REPOCEUTICALS A/S.
On June 18, 2019, the company changed its name from REPOCEUTICALS ApS to REPOCEUTICALS A/S.
REPOCEUTICALS A/S has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -383,311.
As of May 22, 2019, NIELS ERIK JESPERSEN HOLDING ApS is registered as an owner of REPOCEUTICALS A/S with an ownership share of 10%.
REPOCEUTICALS A/S has published its annual report for 2017. The net result was DKK -77,881.
REPOCEUTICALS A/S has published its annual report for 2016. The net result was DKK -211,162.
As of August 17, 2016, CLINICURO ApS is registered as an owner of REPOCEUTICALS A/S with an ownership share of 5%.
REPOCEUTICALS A/S has published its annual report for 2015. The net result was DKK -34,034.
As of June 20, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of REPOCEUTICALS A/S.
As of April 20, 2016, Torsten Bjørn is registered as director of REPOCEUTICALS A/S.
As of April 20, 2016, Henrik Lasse Lindblad has stepped down as director of REPOCEUTICALS A/S.
As of January 16, 2015, Henrik Lasse Lindblad is registered as director of REPOCEUTICALS A/S.
REPOCEUTICALS A/S was founded on January 16, 2015.
Companies in the same industry and area
CVR 30082346
CVR 37509736
CVR 39161672
CVR 41489189
CVR 44807866
